Biolex Therapeutics' Series B Round

Biolex Therapeutics raised a round of funding on September 13, 2005.

Biolex Therapeutics is a clinical-stage biopharmaceutical company that uses the LEX System to develop follow-on biologics, hard-to-make therapeutic proteins and monoclonal antibodies that have been op…

Articles about Biolex Therapeutics' Series B Round: